Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 7, 2020
Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD StudyGrigoris T Gerotziafas, Theodoros Zografos, Ioannis Pantos, et al.
BMC Gastroenterology|March 9, 2023
Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver diseaseClayton S Lewis, Khurram Bari, Changchun Xie, et al.
Thrombosis Research|May 4, 2012
Decreased procoagulant phospholipids in patients treated by vitamin K antagonistsAurélie Rousseau, Barry Woodhams, Michèle Paunet-Bobo, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 30, 2015
Characterization of the antithrombotic fingerprint of the branded and copies of the low-molecular-weight enoxaparin using thrombin generation assayGrigoris T Gerotziafas, Aurèlie Rouseau, Elisabeth Mbemba, et al.
ERJ Open Research|December 16, 2021
Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndromeEtienne-Marie Jutant, Guillaume Voiriot, Vincent Labbé, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 5, 2011
Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factorAurélien Delluc, Aurélie Rousseau, Céline Delluc, et al.
Thrombosis and Haemostasis|October 4, 2002
Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?Emmanuel Oger, Karine Lacut, Grégoire Le Gal, et al.
British Journal of Haematology|May 25, 2002
On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activationGrigoris T Gerotziafas, Kostas Zervas, Pantelis Arzoglou, et al.
Haematologica|April 12, 2003
High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderlyEmmanuel Oger, Karine Lacut, Patrick Van Dreden, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clotsStella Salta, Loula Papageorgiou, Annette K Larsen, et al.
Pageof 6